Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 37
The chemistry of heterocycles in the 21st century
Valery N. Charushin, Egor V. Verbitskiy, О. Н. Чупахин, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 7, pp. RCR5125-RCR5125
Closed Access | Times Cited: 24
An update on animal models of intervertebral disc degeneration and low back pain: Exploring the potential of artificial intelligence to improve research analysis and development of prospective therapeutics
Mauro Alini, Ashish D. Diwan, W. Mark Erwin, et al.
JOR Spine (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 26
A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives
Shopnil Akash, Farjana Islam Aovi, AK Azad, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0283271-e0283271
Open Access | Times Cited: 14
Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment
Jinyang Zhao, Fan Xia, Xue Jiao, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 5
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3805-3805
Open Access | Times Cited: 4
Current situation, trend, and prospects of research on functional components from by-products of baijiu production: A review
Yunsong Jiang, Jinyuan Sun, Jayani Chandrapala, et al.
Food Research International (2024) Vol. 180, pp. 114032-114032
Closed Access | Times Cited: 2
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 1
Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression
Francesca Beretti, Martina Gatti, Francesco Ricchi, et al.
Experimental Neurology (2024) Vol. 380, pp. 114908-114908
Closed Access | Times Cited: 1
The possible role of gut microbiota dysbiosis in the pathophysiology of delirium in older persons
Andrea Ticinesi, Alberto Parise, Antonio Nouvenne, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 3, pp. 19-19
Open Access | Times Cited: 3
Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C
Sandeep, Rhea Subba, Amal Chandra Mondal
Molecular Neurobiology (2023) Vol. 61, Iss. 12, pp. 9945-9960
Closed Access | Times Cited: 3
Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation
Mulan Chen, Xin He, Yepeng Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
Joanna Motyl, Grażyna Gromadzka, Grzegorz A. Czapski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12079-12079
Open Access
In Vitro biological evaluation of some hybrid molecules bearing 2-quinoline as anti-inflammatory and anti-cancer agents
Adil Aldhahrani, Najla A. Alshaye, Dalal Sulaiman Alshaya, et al.
Journal of Molecular Structure (2024), pp. 141060-141060
Closed Access
Aging and long COVID-19 syndrome: what’s new in 2023?
Ray Marks
MOJ Gerontology & Geriatrics (2023) Vol. 8, Iss. 1, pp. 9-14
Open Access
Deterioro cognitivo post-COVID-19: definiciones, fisiopatología, clínica y tratamientos
Omar Delgado-Martínez, Raymundo Solís-Gómez, Ramiro Ruiz‐Garcia
Revista de Neuro-Psiquiatría (2023) Vol. 86, Iss. 4, pp. 289-301
Open Access
Page 1

Scroll to top